Infusion of T-Regulatory Cells in Kidney Transplant Recipients (The ONE Study)

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

March 2, 2016

Study Completion Date

March 2, 2016

Conditions
Kidney Failure, Kidney Transplant
Interventions
BIOLOGICAL

T Regulatory Cell Infusion

After blood is collected from the donor and recipient, the facility will sort out one particular kind of immune cell called a regulatory T cell which is strongly influenced by tolerance induction to minimize (suppress) responses to the donor cells. In this study, these regulatory T cells are the cells which will be given back to the recipient on Day 7 (+3 days) post-transplant.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

University of Regensburg

OTHER

lead

Massachusetts General Hospital

OTHER

NCT02091232 - Infusion of T-Regulatory Cells in Kidney Transplant Recipients (The ONE Study) | Biotech Hunter | Biotech Hunter